Evidence map›Paper›PMID 32918763›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.

Muhammed S Muyyarikkandy, Marc McLeod, Meghan Maguire, Rohit Mahar, Nathan Kattapuram, Christine Zhang, Chaitra Surugihalli, Vaishna Muralidaran, Kruthi Vavilikolanu, Clayton E Mathews and 2 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. In vivoCurrent opinion in biotechnology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Muhammed S MuyyarikkandyDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Marc McLeodDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
Meghan MaguireDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Rohit MaharDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
Nathan KattapuramDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Christine ZhangDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Chaitra SurugihalliDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Vaishna MuralidaranDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Kruthi VavilikolanuDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
Clayton E MathewsDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
Matthew E MerrittDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
Nishanth E SunnyDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD, USA.
University of Maryland, College Park · USUniversity of Florida · US

Funding

TR&D3-SCHP41GM122698 · NIGMS · FLORIDA STATE UNIVERSITY · PI BREY, WILLIAM W, CROSS, TIMOTHY A · 2017 to 2021
$6.7M
Web Portal CoreU2CDK119889 · NIDDK · UNIVERSITY OF FLORIDA · PI CONLON, MICHAEL, GARRETT, TIMOTHY J · 2018 to 2021
$1.9M
Metabolic Origins of Nonalcoholic SteatohepatitisR01DK112865 · NIDDK · UNIV OF MARYLAND, COLLEGE PARK · PI SUNNY, NISHANTH · 2017 to 2021
$1.8M
Imaging Hepatic Gluconeogenesis with Hyperpolarized DihydroxyacetoneR01DK105346 · NIDDK · UNIVERSITY OF FLORIDA · PI MERRITT, MATTHEW E · 2016 to 2020
$1.7M
NIDDK NIH HHS R01 DK105346NIDDK NIH HHS R01 DK112865NIDDK NIH HHS U2C DK119889NIGMS NIH HHS P41 GM122698
6 · The paper itself

Abstract

Mitochondrial adaptation during non-alcoholic fatty liver disease (NAFLD) include remodeling of ketogenic flux and sustained tricarboxylic acid (TCA) cycle activity, which are concurrent to onset of oxidative stress. Over 70% of obese humans have NAFLD and ketogenic diets are common weight loss strategies. However, the effectiveness of ketogenic diets toward alleviating NAFLD remains unclear. We hypothesized that chronic ketogenesis will worsen metabolic dysfunction and oxidative stress during NAFLD. Mice (C57BL/6) were kept (for 16-wks) on either a low-fat, high-fat, or high-fat diet supplemented with 1.5X branched chain amino acids (BCAAs) by replacing carbohydrate calories (ketogenic). The ketogenic diet induced hepatic lipid oxidation and ketogenesis, and produced multifaceted changes in flux through the individual steps of the TCA cycle. Higher rates of hepatic oxidative fluxes fueled by the ketogenic diet paralleled lower rates of de novo lipogenesis. Interestingly, this metabolic remodeling did not improve insulin resistance, but induced fibrogenic genes and inflammation in the liver. Under a chronic "ketogenic environment," the hepatocyte diverted more acetyl-CoA away from lipogenesis toward ketogenesis and TCA cycle, a milieu which can hasten oxidative stress and inflammation. In summary, chronic exposure to ketogenic environment during obesity and NAFLD has the potential to aggravate hepatic mitochondrial dysfunction.

Indexed as

Oxidative StressAmino Acids, Branched-ChainAnimalsCarbohydrate MetabolismCitric Acid CycleDiet, KetogenicLipogenesisLiverMaleMiceMice, Inbred C57BLMitochondria, LiverNon-alcoholic Fatty Liver DiseaseAmino Acids, Branched-Chainfatty liverhepatic insulin resistancelipogenesisliver mitochondria

Identifiers

PMID32918763
PMCPMC7716091
OpenAlexW3086152977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.